Results 81 to 90 of about 2,929 (132)

Quantitative analysis of proteomic changes in two monoclonal suspension MDCK cell lines infected with human influenza A virus (H1N1). [PDF]

PLoS One
Küchler J, Zinnecker T, Hellwig P, Wolf M, Benndorf D, Genzel Y, Reichl U.   +6 more
europepmc   +1 more source

Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus. [PDF]

Vaccines (Basel)
Ndlovu B, van Zyl AR, Verwoerd D, Rybicki EP, Hitzeroth II.   +4 more
europepmc   +1 more source

m6A-Modified Nucleotide Bases Improve Translation of In Vitro-Transcribed Chimeric Antigen Receptor (CAR) mRNA in T Cells. [PDF]

Int J Mol Sci
Lao N, Li S, Ainciburu M, Barron N.
europepmc   +1 more source

Real-Time VCC Monitoring and Forecasting in HEK-Cell-Based rAAV Vector Production Using Capacitance Spectroscopy. [PDF]

Eng Life Sci
Machleid R, Nunna S, George A, Austerjost J, Tomala M, Surowiec I.   +5 more
europepmc   +1 more source

Yeast vaccine production platform for human and animal infectious diseases. [PDF]

Front Immunol
Ramos-Vega A, Monreal-Escalante E, Bañuelos-Hernández B, Angulo M, Trujillo E, Angulo C.   +5 more
europepmc   +1 more source

Micropropagation of transgenic lettuce containing HBsAg as a method of mass-scale production of standardised plant material for biofarming purposes [PDF]

core   +1 more source

Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient Transfection. [PDF]

Vaccines (Basel)
Hajduczki A, Chang WC, De La Barrera R, Wood JF, Chen WH, Martinez EJ, Jensen JL, Sankhala RS, Smith C, Anderson A, Morrison EB, Peterson CE, Rees PA, Soman S, Kuklis C, Ahmed A, King J, Nasar F, Corbitt C, Choe M, Thomas PV, Zemil M, Wieczorek L, Polonis VR, Dooley HM, Mascola JR, de Val N, Matyas GR, Rao M, Gromowski GD, Modjarrad K, Vasan S, Froude JW, Michael NL, Joyce MG, Zarling S.   +35 more
europepmc   +1 more source

Accelerated vaccine process development by orthogonal protein characterization. [PDF]

Sci Rep
James DA, Szymkowicz L, Yin L, Shah H, Leach M, Chicz RM.   +5 more
europepmc   +1 more source

production of a novel glycoconjugate vaccine against 2a in recombinant identification of stimulating factors for glycosylation [PDF]

core   +1 more source

<i>Bacillus subtilis</i> Spores as a Vaccine Delivery Platform: A Tool for Resilient Health Defense in Low- and Middle-Income Countries. [PDF]

Vaccines (Basel)
Hazan A, Lee HY, Tiong V, AbuBakar S.
europepmc   +1 more source